Scandinavian Medical Solutions AS (SMSMED) — Cash Flow Reinvestment Rate

Latest as of September 2024: 0.85x

Scandinavian Medical Solutions AS (SMSMED) has a Cash Flow Reinvestment Rate of 0.85x as of September 2024, reinvesting Dkr15.13 Million (capex Dkr15.13 Million ) from operating cash flow of Dkr17.86 Million. Explore SMSMED capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.85x
(Capex + Investments) / Operating CF

Total Reinvested

Dkr15.13 Million
Capex + Investments

Operating Cash Flow

Dkr17.86 Million
DKK

Capital Expenditures

Dkr15.13 Million
DKK

Scandinavian Medical Solutions AS Cash Flow Reinvestment Rate (2020–2024)

Historical reinvestment intensity for Scandinavian Medical Solutions AS across 3 annual periods. Also explore SMSMED total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Scandinavian Medical Solutions AS (2020–2024)

Year-by-year capital reinvestment analysis for Scandinavian Medical Solutions AS. For live market cap and broader valuation context, see market cap of Scandinavian Medical Solutions AS.

Year Reinvestment Rate Total Reinvested (DKK) Operating CF Capex YoY Change
2024 5.53x Dkr18.77 Million Dkr3.39 Million Dkr18.47 Million ▲ +8193.5%
2021 0.07x Dkr268.50K Dkr4.02 Million Dkr5.00 ▼ -95.5%
2020 1.47x Dkr13.79 Million Dkr9.38 Million Dkr13.76 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow